- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on B-cell Lymphoma Refractory
Total 7660 results
-
University of NebraskaRecruitingLymphoma | Multiple MyelomaUnited States
-
Keymed Biosciences Co.LtdRecruitingLymphoma | Multiple MyelomaChina
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
Hospital Universitario Dr. Jose E. GonzalezCompletedLymphoma | Myeloma MultipleMexico
-
Maastricht University Medical CenterCompletedLymphoma | Myeloma MultipleNetherlands
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Sheba Medical CenterUnknown
-
University Hospital, MontpellierCompletedCentral Nervous System LymphomaFrance
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico, South Africa
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, United Kingdom, Sweden
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompleted
-
Infinity Pharmaceuticals, Inc.Active, not recruitingAdvanced Solid Tumors (Part A/B/C/D) | Non-small Cell Lung Cancer (Part E) | Melanoma (Part E) | Squamous Cell Cancer of the Head and Neck (Part E) | Triple Negative Breast Cancer (Part F) | Adrenocortical Carcinoma (Part G) | Mesothelioma (Part G) | High-circulating Myeloid-derived Suppressor Cells...United States
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Peking Union Medical College HospitalBetta Pharmaceuticals Co., Ltd.RecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma Kinase I1171N | EnsartinibChina
-
Cedars-Sinai Medical CenterCompletedLymphoma | Multiple Myeloma | Transplant-Related DisorderUnited States
-
Centre Hospitalier Universitaire de Saint EtienneLEO PharmaCompletedLymphoma | Multiple MyelomaFrance
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
LifeTime PharmaceuticalsUnknown
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
M.D. Anderson Cancer CenterCompletedLymphoma | Multiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedLymphoma | Small Intestine Cancer | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Robert Leet...Active, not recruitingMultiple Sclerosis | Autoimmune Blistering Disease | B-Cell DeficiencyUnited States
-
OncotherapeuticsNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Marcela V. Maus, M.D.,Ph.D.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Jack KhouriNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Cytokine Release Syndrome | Immune Effector Cell Associated Neurotoxicity SyndromeUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Refractory Sclerodermatous Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNot yet recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Andrew Yee, MDJanssen Research & Development, LLC; AmgenRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse | Multiple Myeloma in RelapseUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.CompletedWaldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia RefractoryChina
-
PfizerActive, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Myeloma | Relapsed Multiple Myeloma | Elranatamab | PF-06863135 | BCMA | Bispecific | Bispecific Antibody | BCMA-CD3 Bispecific | MagnetisMM-8China
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Thrombocytopenia | Refractory Multiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Terminated
-
Peking Union Medical College HospitalUnknownLymphoma | Multiple MyelomaChina
-
University of FloridaCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Georgetown UniversityDaiichi Sankyo, Inc.Terminated
-
Chong Kun Dang PharmaceuticalCompletedLymphoma | Multiple MyelomaKorea, Republic of
-
Genzyme, a Sanofi CompanyEuropean Society for Blood and Marrow TransplantationCompletedLymphoma | Acute Leukemia | Myelodysplastic Syndrome | Solid Tumors | Myeloproliferative Neoplasm | Chronic Leukemia | Plasma Cell Disorders
-
Taunton and Somerset HospitalCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedLymphomaUnited States
-
National Cancer Institute (NCI)CompletedThrombocytopenia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13... and other conditionsUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of California, DavisCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States